National Coverage Analyses Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease CMS will not be issuing a proposed NCD on Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease today. A proposed decision is forthcoming after CMS has reviewed newly published evidence that is relevant to the proposed NCD. https://www.cms.gov/medicare-coverage-database/view/ncacal-tracking-sheet.aspx?ncaid=308&ncacaldoctype=all&status=all&sortBy=status&bc=17 |